(Q40691464)

22 September 2017

Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and Cyclophosphamide (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

7 March 2023

1 reference

Donadio JV Jr

1

1 reference

22 September 2017

J. V. Donadio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A309095

7 March 2023

K. E. Holley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A309095

7 March 2023

R. H. Ferguson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A309095

7 March 2023

D. M. Ilstrup

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A309095

7 March 2023

language of work or name

English

0 references

publication date

1 November 1978

1 reference

22 September 2017

23 November 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=309095

full work available at URL

7 March 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197811232992102

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

The New England Journal of Medicine

7 March 2023

published in

1 reference

22 September 2017

299

1 reference

22 September 2017

1151-1155

1 reference

22 September 2017

21

1 reference

Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine

22 September 2017

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months

7 March 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

7 March 2023

4

51

484

Donadio

1976

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

The Effect of Treatment with Prednisone and Nitrogen Mustard on the Renal Lesions and Life Span of Patients with Lupus Glomerulonephritis

7 March 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

Criteria for the classification of systemic lupus erythematosus--status 1972.

7 March 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

7 March 2023

7

50

121

Velosa

1975

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

Detection of circulating immune complexes in patients with glomerulonephritis

7 March 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).

7 March 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis

7 March 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

Immune potential in human uraemia. 1. Relationship of glomerular filtration rate to depression of immune potential

7 March 2023

15

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

The bimodal mortality pattern of systemic lupus erythematosus

7 March 2023

16

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

Lupus nephritis. Clinical course as related to morphologic forms and their transitions

7 March 2023

17

1 reference

https://api.crossref.org/works/10.1056/NEJM197811232992102

7 March 2023

Identifiers

1 reference

22 September 2017

1 reference